Investigation of a genetic variation of a variable number tandem repeat polymorphism of interleukin-6 gene in patients with multiple sclerosis

Journal of Neurology

Volumn 250, Issue 5, 2003, Pages 607-611

  Schmidt, Stephan ^a   Papassotiropoulos, Andreas ^a   Sotgiu, Stefano ^d   Kölsch, Heike ^a   Arru, Giannina ^d   Fois, Maria Laura ^d   Haase, Claus G ^b   Schmitz, Sandra ^a   König, Nicolaus ^c   Harzheim, Michael ^a   Heun, Reinhard ^a   Klockgether, Thomas ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c Multiple Sclerosis Center   (Germany)

^d UNIVERSITY OF SASSARI   (Italy)

Author keywords

Genetic polymorphisms; Interleukin 6 gene; Multiple sclerosis

Indexed keywords

INTERLEUKIN 6;

ADULT; ALLELISM; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DISEASE COURSE; DNA FLANKING REGION; FEMALE; GENE FREQUENCY; GENE LOCATION; GENETIC ANALYSIS; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GERMANY; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; PHENOTYPIC VARIATION; POPULATION GENETICS; PRIORITY JOURNAL; RISK ASSESSMENT; TANDEM REPEAT;

ADULT; ALLELES; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; CYTOSINE; FEMALE; GENOTYPE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MINISATELLITE REPEATS; MULTIPLE SCLEROSIS; POLYMORPHISM, GENETIC; VARIATION (GENETICS);

EID: 0037565162     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-003-1051-y     Document Type: Article

References (27)

1. Martin R, McFarland H, McFarlin D (1992) Immunological aspects of demyelinating disease. Annu Rev Immunol 10:153-187
2. Ebers G, Dyment D (1998) Genetics of multiple sclerosis. Semin Neurol 18:295-299
3. Chataway J, Feakes R, Coraddu F, Gray J, Deans J, Fraser M, Robertson N, Broadley S, Jones H, Clayton D, Goodfellow P, Sawcer S, Compston A (1998) The genetics of Multiple Sclerosis: principles, background and updated results of the United Kingdom systematic genome screen. Brain 121:1869-1887
4. Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, Ebers J (1989) The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 112:133-146
5. Thompson AJ, Polman CH, Miller DH, McDonald WI, Brochet B, Filippi M, Montalban X, De Sá J (1997) Primary progressive multiple sclerosis. Brain 120:1085-1096
6. Lucchinetti CL, Brück WB, Rodriguez M, Lassmann H (1996) Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol 6:259-274
7. Giess R, Mäurer M, Linker R, Gold R, Warmuth-Metz M, Toyka KV, Sendtner M, Rieckmann P (2002) Association of a null mutation in the CNTF gene with early onset of multiple sclerosis. Arch Neurol 59:407-409
8. Fazekas F, Strasser-Fuchs S, Kollegger H, Berger T, Kristoferitsch W, Schmidt H, Enzinger C, Schiefermeier M, Schwarz C, Kornek B, Reindl M, Huber K, Grass R, Wimmer G, Vass K, Pfeiffer KH, Hartung HP, Schmidt R (2001) Apolipoprotein E ε4 is associated with rapid progression of multiple sclerosis. Neurology 57:853-857
9. Vandenbroeck K, Fiten P, Ronsse I, Goris A, Porru I, Melis C, Rolesu M, Billiau A, Marrosu MG, Odenakker G (2000) High-resolution analysis of IL-6 minisatellite polymorphism in Sardinian multiple sclerosis: effect on course and onset of disease. Genes and Immunity 1:460-463
10. Papassotiropoulos A, Bagli M, Jessen F, Bayer AT, Maier W, Rao ML, Heun R (1999) A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease. Ann Neurol 45:666-668
11. Linker-Israeli M, Wallace DJ, Prehn J, Michael D, Honda M, Taylor KD, Paul-Labrador M, Fischel-Ghodsian N, Fraser PA, Klinenberg JR (1999) Association of IL-6 gene alleles with systemic lupus erythematodes (SLE) and with elevated IL-6 expression. Genes Immun 1:45-52
12. Padberg F, Feneberg W, Schmidt S, Schwarz MJ, Korschenhausen D, Greenberg BD, Nolde T, Müller N, Trapman H, König N, Möller HJ, Hampel H (1999) CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis. J Neuroimmunol 99:218-223
13. Navikas V, Matusevicius D, Soderström M, Frederikson S, Kivisakk P, Ljungdahl A, Hojeberg B, Link H (1996) Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis. J Neuroimmunol 64:63-69
14. Eugster HP, Frei K, Kopf M, Lassmann H, Fontana A (1998) IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur J Immunol 28:2178-2187
15. Gijbels K, Brocke S, Abrams JS, Steinman L (1995) Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation. Mol Med 1:795-805
16. Schmidt S, Papassotiropoulos A, Bagli M, Harzheim M, Heun R, Klockgether T (2000) No association of serum levels of interleukin-6 and its soluble receptor components with a genetic variation in the 3′flanking region of the interleukin-6 gene in patients with multiple sclerosis. Neurosci Lett 294:139-142
17. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtelotte WW (1983) New diagnostic criteria for Multiple Sclerosis: guidelines for research protocols. Ann Neurol 13:227-231
18. Pugliati M, Solinas G, Sotgiu S, Castiglia P, Rosati G (2002) Multiple sclerosis distribution in northern Sardinia. Spatial cluster analysis of prevalence. Neurology 58:277-282
19. Lublin F, Reingold S (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46:907-911
20. Kurtzke IF (1983) Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 33:1444-1452
21. Heun R, Papassotiropoulos A, Jessen F, Maier W, Breitner JC (2001) A family study of Alzheimer disease and early- and late-onset depression in elderly patients. Arch Gen Psychiatry 58:190-196
22. Bowcock AM, Ray A, Ehrlich H, Sehgal PB (1989) Rapid detection and sequencing of alleles in the 3′flanking region of the interleukin-6 gene. Nucleic Acids Res 17:6855-6864
23. Murray RE, McGuigan F, Grant SF, Reid DM, Ralston SH (1997) Polymorphisms of the interleukin-6 gene are associated with bone mineral density. Bone 21:89-92
24. Papassotiropoulos A, Hock C, Nitsch RM (2001) Genetics of interleukin 6: implications for Alzheimer's disease. Neurobiol Aging 22:863-871
25. Marrosu MG, Muntoni F, Murru MR, Spinicci G, Pischedda MP, Goddi F, Cossu F, Pirastu M (1988) Sardinian multiple sclerosis is associated with HLA-DR 4: a serologic and molecular analysis. Neurology 38:1749-1753
26. Marrosu MG, Muntoni F, Murru MR, Costa G, Pischedda MP, Pirastu M, Sotgiu S, Rosati G, Cianchetti C (1992) HLA-DQB1 genotype in Sardinian multiple sclerosis: evidence for a key role of DQB1*0210 and *0302 alleles. Neurology 42:883-886
27. Sotgiu S, Pugliatti M, Sanna A, Sotgiu A, Castiglia P, Solinas G, Dolei A, Serra C, Bonetti B, Rosati G (2002) Multiple sclerosis complexity in selected populations: the challenge of Sardinia, insular Italy. Eur J Neurol 9:329-341